Tag: GDP

Addressing Audit Trail Gaps Found in Data Review – A Comprehensive Guide for Inspectors The increasing reliance on electronic systems in the pharmaceutical industry brings challenges, particularly concerning audit trails.…

“`html Addressing Recurring Data Integrity Issues in Laboratory Walkthroughs: A Comprehensive Playbook Data integrity remains a critical component in pharmaceutical manufacturing and quality control. Instances of repeat data integrity lapses…

“`html Mitigating Risks of Unsecured Raw Data Storage during Data Review in Pharma Unsecured raw data storage during data review can lead to significant compliance risks, potentially escalating into regulatory…

“`html Addressing Recurring Data Integrity Issues Identified During Internal Audits In the highly regulated pharmaceutical environment, repeat data integrity lapses during internal audits can severely undermine confidence in the Quality…

Addressing Unsecured Raw Data Storage During Laboratory Walkthroughs: An Effective CAPA Playbook Laboratories often face challenges related to data integrity, particularly concerning the storage of raw data. Unsecured raw data…

Addressing Risks of Unsecured Raw Data Storage During FDA Inspections In pharmaceutical manufacturing, data integrity is essential to ensure product safety and regulatory compliance. One key concern arises when raw…

Actionable Playbook for Addressing Insufficient Data Integrity Governance in Laboratory Walkthroughs Inadequate data integrity (DI) governance can significantly impact laboratory operations, leading to potential compliance issues during regulatory inspections. This…

“`html Managing Shared User Credentials during Internal Audits to Avoid Regulatory Escalation In the world of pharmaceutical manufacturing and quality, maintaining data integrity is paramount. One common issue that can…

Managing Manual Data Transcription During FDA Inspections: An Essential Guide for Quality Assurance In today’s fast-paced and heavily regulated pharmaceutical environment, manual data transcription without verification is a significant risk…

“`html Roadmap for Remediation of Inadequate Data Integrity Governance During FDA Inspections In the pharmaceutical industry, data integrity (DI) is critical for ensuring compliance with regulatory requirements and maintaining product…

Addressing the Issues with Shared User Credentials in System Validation: A Comprehensive Playbook for CAPA Effectiveness The pharmaceutical industry is increasingly reliant on automated systems to ensure compliance with Good…

Playbook for Addressing Recurring Data Integrity Issues in Laboratory Walkthroughs Data integrity lapses during laboratory walkthroughs can pose significant challenges to pharmaceutical manufacturing and quality assurance professionals. Such failures not…